Re: Anacetrapib Officially Bites the Dust
in response to
by
posted on
Oct 26, 2017 03:09PM
So I guess the question with CEPT inhibitors almost in the grave, given that it was the big companies that put their money into developing and testing this theory and having it fail what might this imply about a "tiny little Calgary based biotech with what is seemingly little credibility".
I'd be amazed if this does not focus serious attention on RVX and yet the CEPT failures are not new.
IMO
Toinv